Press Release: Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

Dow JonesMay 2 11:48 ET

Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

BenzingaMay 2 05:02 ET

EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders

BenzingaMay 1 08:02 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'New Patent Covers a Treatment Method for a Broad Spectrum of Alcohol-related Disorders, Including Additional Conditions Associated With Alcohol Use'

BenzingaMay 1 08:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Expands Intellectual Property Portfolio With New US Patent Granted For Genetic-Based Treatment Of Alcohol And Opioid Use Disorders

BenzingaMay 1 08:00 ET

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaApr 21 17:05 ET

Adial Pharmaceuticals Appoints Tony Goodman as COO

TipRanksMar 21 16:55 ET

Express News | Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate

BenzingaMar 4 09:50 ET

10-K: FY2024 Annual Report

SECMar 4 08:50 ET · Announcements

Adial Pharmaceuticals Expects Cash to Fund Operations Into 2H of 2025

TipRanksMar 4 08:36 ET

Adial Pharma Believes Existing Cash and Cash Equivalents Will Fund Oper Expenses Into 2H

Dow JonesMar 4 08:31 ET

Express News | Adial Pharmaceuticals FY Net Income USD -13.2 Million

ReutersMar 4 08:30 ET

Adial Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Feedback for Its Vitro Bridging Strategy of AD04 and Will Proceed to Manufacture Clinical Supplies for Its Upcoming Phase 3 Clinical Trial.

BenzingaFeb 25 09:05 ET

Express News | Adial Pharmaceuticals Receives Positive Response From FDA Meeting Regarding Proposed in Vitro Bridging Strategy for Ad04

ReutersFeb 25 09:00 ET

Adial Pharmaceuticals Receives Positive Response From FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

GlobeNewswireFeb 25 09:00 ET

EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder

BenzingaFeb 25 08:30 ET

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

GlobeNewswireFeb 12 09:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'New Patent Expands Patent Estate Covering Adial's Unique Molecular Genetic Approach to Diagnosing and Potentially Treating Alcohol and Drug Dependence'

BenzingaFeb 12 08:30 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Awarded New U.S Patent Covering Genotype-Specific Treatment Of Opioid -Related Disorders

BenzingaFeb 12 08:30 ET

EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

BenzingaFeb 12 08:30 ET